The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy
Abstract
Live attenuated bacteria are of increasing importance in biotechnology and medicine in the emerging field of cancer immunotherapy. Oral DNA vaccination mediated by live attenuated bacteria often suffers from low infection efficiency due to various biological barriers during the infection process. To this end, we herein report, for the first time, a new strategy to engineer cationic nanoparticle-coated bacterial vectors that can efficiently deliver oral DNA vaccine for efficacious cancer immunotherapy. By coating live attenuated bacteria with synthetic nanoparticles self-assembled from cationic polymers and plasmid DNA, the protective nanoparticle coating layer is able to facilitate bacteria to effectively escape phagosomes, significantly enhance the acid tolerance of bacteria in stomach and intestines, and greatly promote dissemination of bacteria into blood circulation after oral administration. Most importantly, oral delivery of DNA vaccines encoding autologous vascular endothelial growth factor receptor 2 (VEGFR2) by this hybrid vector showed remarkable T cell activation and cytokine production. Successful inhibition of tumor growth was also achieved by efficient oral delivery of VEGFR2 with nanoparticle-coated bacterial vectors due to angiogenesis suppression in the tumor vasculature and tumor necrosis. This proof-of-concept work demonstrates that coating live bacterial cells with synthetic nanoparticles represents a promising strategy to engineer efficient and versatile DNA vaccines for the era of immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Cross, M. J., & Claesson-Welsh, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01676-x · Cited by 989
The IL-12 Family of Heterodimeric Cytokines
Trinchieri, G., Pflanz, S., & Kastelein, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00296-6 · Cited by 922
Eberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., & Augustin, H. G. (2000) · PubMed · Cited by 873
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Cyclodextrin-Based Host–Guest Supramolecular Nanoparticles for Delivery: From Design to Applications
Hu, Q.-D., Tang, G.-P., & Chu, P. K. (2014) · Accounts of Chemical Research · doi:10.1021/ar500055s · Cited by 525
Self-citationAcid resistance in enteric bacteria
Gorden, J., & Small, P. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.364-367.1993 · Cited by 444
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., & Reisfeld, R. A. (2002) · Nature Medicine · doi:10.1038/nm1202-794 · Cited by 400
SALMONELLOSIS: Host Immune Responses and Bacterial Virulence Determinants1
Jones, B. D., & Falkow, S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.533 · Cited by 385
Synthesis and patterning of tunable multiscale materials with engineered cells
Chen, A. Y., Deng, Z., Billings, A. N., Seker, U. O. S., Lu, M. Y., Citorik, R. J., Zakeri, B., & Lu, T. K. (2014) · Nature Materials · doi:10.1038/nmat3912 · Cited by 379
VEGF: an update on biological and therapeutic aspects
Ferrara, N. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00153-1 · Cited by 372
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
Grothey, A., & Galanis, E. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.110 · Cited by 356
Bacteria-mediated delivery of nanoparticles and cargo into cells
Akin, D., Sturgis, J., Ragheb, K., Sherman, D., Burkholder, K., Robinson, J. P., Bhunia, A. K., Mohammed, S., & Bashir, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.149 · Cited by 347
Tumor angiogenesis and tissue factor
Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0296-167 · Cited by 293
Yang, C., Ding, X., Ono, R. J., Lee, H., Hsu, L. Y., Tong, Y. W., Hedrick, J., & Yang, Y. Y. (2014) · Advanced Materials · doi:10.1002/adma.201402059 · Cited by 261
Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma
McDermott, D., Lebbé, C., Hodi, F. S., Maio, M., Weber, J. S., Wolchok, J. D., Thompson, J. A., & Balch, C. M. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.06.012 · Cited by 202
Probiotics: from research to consumer
Del Piano, M., Morelli, L., Strozzi, G. P., Allesina, S., Barba, M., Deidda, F., Lorenzini, P., Ballaré, M., Montino, F., Orsello, M., et al. (2006) · Digestive and Liver Disease · doi:10.1016/s1590-8658(07)60004-8 · Cited by 199
Interferon‐γ plays a critical role in intestinal immunity against Salmonella typhimurium infection
Bao, S., Beagley, K. W., France, M. P., Shen, J., & Husband, A. J. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00955.x · Cited by 185
Thamm, D. H., Kurzman, I. D., King, I., Li, Z., Sznol, M., Dubielzig, R. R., Vail, D. M., & MacEwen, E. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2510 · Cited by 174
Tang, G. P., Guo, H. Y., Alexis, F., Wang, X., Zeng, S., Lim, T. M., Ding, J., Yang, Y. Y., & Wang, S. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.874 · Cited by 169
Self-citationBacteria-instructed synthesis of polymers for self-selective microbial binding and labelling
Magennis, E. P., Fernandez-Trillo, F., Sui, C., Spain, S. G., Bradshaw, D. J., Churchley, D., Mantovani, G., Winzer, K., & Alexander, C. (2014) · Nature Materials · doi:10.1038/nmat3949 · Cited by 167
An autologous oral DNA vaccine protects against murine melanoma
Xiang, R., Lode, H. N., Chao, T.-H., Ruehlmann, J. M., Dolman, C. S., Rodrı́guez, F., Whitton, J. L., Overwijk, W. W., Restifo, N. P., & Reisfeld, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090097697 · Cited by 156
Yuan, P., Hu, Q., Tang, G., & Li, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.071 · Cited by 156
Self-citationBacterial Ghosts Are an Efficient Delivery System for DNA Vaccines
Ebensen, T., Paukner, S., Link, C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6858 · Cited by 115
Polymeric nano- and microparticle technologies for oral gene delivery
Bhavsar, M. D., & Amiji, M. M. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.3.197 · Cited by 105
Feng, X., Yang, G., Liu, L., Lv, F., Yang, Q., Wang, S., & Zhu, D. (2011) · Advanced Materials · doi:10.1002/adma.201102026 · Cited by 100
Regulation of Tumor Growth by IFN-Γ in Cancer Immunotherapy
Beatty, G. L., & Paterson, Y. Y. W. (2001) · Immunologic Research · doi:10.1385/ir:24:2:201 · Cited by 96
Live-attenuated bacteria as a cancer vaccine vector
Toussaint, B., Chauchet, X., Wang, Y., Polack, B., & Gouëllec, A. L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.836914 · Cited by 91
Kaufmann, S. H. E., & Hess, J. (1999) · Immunology Letters · doi:10.1016/s0165-2478(98)00128-x · Cited by 85
Zhu, C., Yang, Q., Lv, F., Liu, L., & Wang, S. (2012) · Advanced Materials · doi:10.1002/adma.201204550 · Cited by 85
Xiang, R., Luo, Y., Niethammer, A. G., & Reisfeld, R. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00613.x · Cited by 81
Antiangiogenic and antivascular therapy for cancer
Taraboletti, G. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00065-0 · Cited by 67
Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models
Jia, L., Wei, D., Sun, Q., Huang, Y., Wu, Q., & Hua, Z. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00503.x · Cited by 61
Therapeutic live vaccines as a potential anticancer strategy
Bolhassani, A., & Zahedifard, F. (2012) · International Journal of Cancer · doi:10.1002/ijc.27640 · Cited by 58
An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy
Liu, M., Li, Z. H., Xu, F., Lai, L., Wang, Q. Q., Tang, G., & Yang, W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.082 · Cited by 47
Self-citationDNA vaccines suppress tumor growth and metastases by the induction of anti‐angiogenesis
Reisfeld, R. A., Niethammer, A. G., Luo, Y., & Xiang, R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00137.x · Cited by 36
A polymer coating applied to Salmonella prevents the binding of Salmonella ‐specific antibodies
Lee, C., Lin, Y., Hsieh, J., Chen, M., & Kuo, W. (2012) · International Journal of Cancer · doi:10.1002/ijc.27700 · Cited by 20
Engineering Bacterial Vectors for Delivery of Genes and Proteins to Antigen-Presenting Cells
Parsa, S., & Pfeifer, B. A. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0600889 · Cited by 18
Cited by
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
DNA Vaccines—How Far From Clinical Use?
Hobernik, D., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113605 · Cited by 457
Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy
Chen, W., Wang, Y., Qin, M., Zhang, X., Zhang, Z., Sun, X., & Gu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b02235 · Cited by 380
Optically-controlled bacterial metabolite for cancer therapy
Zheng, D.-W., Chen, Y., Li, Z.-H., Xu, L., Li, C.-X., Li, B., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03233-9 · Cited by 324
Chen, Q., Bai, H., Wu, W., Huang, G., Li, Y., Wu, M., Tang, G., & Ping, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b02182 · Cited by 304
Self-citation
Metadata
- Authors
- Hu, Q., Wu, M., Fang, C., Cheng, C., Zhao, M., Fang, W., Chu, P. K., Ping, Y., & Tang, G.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-03-30
- Volume
- 15
- Issue
- 4
- Pages
- 2732-2739
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2064472998
- Cited by
- 286
- References
- 44
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.